story of the week
12-Month vs 3-Month Edoxaban in Patients With Cancer and Isolated Distal Deep Vein Thrombosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Circulation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Edoxaban for 12 Months Versus 3 Months in Cancer Patients With Isolated Distal Deep Vein Thrombosis (ONCO DVT study): An Open-label, Multicenter, Randomized Clinical Trial
Circulation 2023 Aug 28;[EPub Ahead of Print], Y Yamashita, T Morimoto, N Muraoka, T Oyakawa, M Umetsu, D Akamatsu, Y Nishimoto, Y Sato, T Takada, K Jujo, Y Minami, Y Ogihara, K Dohi, M Fujita, T Nishikawa, N Ikeda, G Hashimoto, K Otsui, K Mori, D Sueta, Y Tsubata, M Shoji, A Shikama, Y Hosoi, Y Tanabe, R Chatani, K Tsukahara, N Nakanishi, K Kim, S Ikeda, M Mo, Y Yoshikawa, T KimuraFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.